The Biorepository for Scripps Health
BIF
1 other identifier
observational
10,000
1 country
1
Brief Summary
The investigators propose to establish a Biorepository of both diseased and normal tissue collected from subjects undergoing surgery for solid tumor resection. In cooperation with the Scripps Cancer registry, the investigators will also establish an anonymized database of corresponding clinical information including response to treatment, disease status, and recurrence. The Biorepository for Scripps Health will be able to process, preserve, and distribute samples to scientific and medical researchers at Scripps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2009
CompletedStudy Start
First participant enrolled
November 1, 2009
CompletedFirst Posted
Study publicly available on registry
November 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2030
ExpectedJanuary 16, 2025
January 1, 2025
16.1 years
October 29, 2009
January 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Establish a Biorepository of both diseased and normal tissue
Establish a Biorepository of both diseased and normal tissue
six years
Study Arms (1)
Biorepository
Patients undergoing surgical resection of a solid tumor.
Interventions
Eligibility Criteria
Subjects over the age of 18 undergoing surgical resection of solid tumor.
You may qualify if:
- Age 18 or older
- Undergoing surgical resection of solid tumor
- Completion of general surgical consent (authorizing "pathologist to use his or her discretion in the disposition or use of any tissues removed during surgery or other procedure unless otherwise directed by my physician. I understand that tissues that are removed may be used for teaching purposes as well as research, institutional or commercial".)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Scripps Mercy Hospital
San Diego, California, 92103, United States
Biospecimen
We will be collecting solid tumor and adjacent non-diseased tissue from patients undergoing surgical resection of a solid tumor.
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Eric J Topol, MD
Scripps Translational Science Institute and Genomic Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Scripps Translational Science Institute
Study Record Dates
First Submitted
October 29, 2009
First Posted
November 2, 2009
Study Start
November 1, 2009
Primary Completion
December 1, 2025
Study Completion (Estimated)
January 1, 2030
Last Updated
January 16, 2025
Record last verified: 2025-01